Short Interest in Nephros, Inc. (NASDAQ:NEPH) Declines By 30.6%

Nephros, Inc. (NASDAQ:NEPH) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 5,000 shares, a decrease of 30.6% from the January 15th total of 7,200 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 10,900 shares, the days-to-cover ratio is presently 0.5 days.

Nephros Price Performance

Shares of NASDAQ NEPH traded down $0.04 during mid-day trading on Friday, reaching $1.52. 45,495 shares of the company traded hands, compared to its average volume of 9,885. Nephros has a fifty-two week low of $1.36 and a fifty-two week high of $3.73. The firm has a market cap of $16.02 million, a PE ratio of -16.89 and a beta of 1.19. The stock has a fifty day simple moving average of $1.56 and a 200-day simple moving average of $1.64.

Wall Street Analysts Forecast Growth

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $5.00 price objective on shares of Nephros in a report on Tuesday, November 12th.

Hedge Funds Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC bought a new position in shares of Nephros, Inc. (NASDAQ:NEPH) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned 3.98% of Nephros as of its most recent SEC filing. Hedge funds and other institutional investors own 41.10% of the company’s stock.

Nephros Company Profile

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.